These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1400895)

  • 1. Superantigens: biology, immunology, and potential role in disease.
    Drake CG; Kotzin BL
    J Clin Immunol; 1992 May; 12(3):149-62. PubMed ID: 1400895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superantigens: structure and relevance to human disease.
    Johnson HM; Torres BA; Soos JM
    Proc Soc Exp Biol Med; 1996 Jun; 212(2):99-109. PubMed ID: 8650257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Superantigens in human disease].
    Rojas Ramos E; Cisneros González N; Cairo Cueto SM
    Rev Alerg Mex; 1997; 44(3):77-82. PubMed ID: 9377117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of disease by superantigens.
    Torres BA; Johnson HM
    Curr Opin Immunol; 1998 Aug; 10(4):465-70. PubMed ID: 9722924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial superantigens.
    Proft T; Fraser JD
    Clin Exp Immunol; 2003 Sep; 133(3):299-306. PubMed ID: 12930353
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of superantigens in infectious diseases].
    Santolaya ME
    Rev Med Chil; 1998 Jul; 126(7):846-54. PubMed ID: 9830779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral superantigens].
    Lafon M
    Rev Med Interne; 2000 Aug; 21(8):713-6. PubMed ID: 10989504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigens and their role in infectious disease.
    Schafer R; Sheil JM
    Adv Pediatr Infect Dis; 1995; 10():369-90. PubMed ID: 7718212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigens in dermatology.
    Macias ES; Pereira FA; Rietkerk W; Safai B
    J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis of T cell activation by superantigens.
    Li H; Llera A; Malchiodi EL; Mariuzza RA
    Annu Rev Immunol; 1999; 17():435-66. PubMed ID: 10358765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superantigens and their possible involvement in psoriasis and other diseases].
    Nemţişor E
    Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):52-5. PubMed ID: 9455436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of superantigens in skin disease.
    Leung DY; Travers JB; Norris DA
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):37S-42S. PubMed ID: 7615995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superantigens.
    Chatila T; Geha RS
    Curr Opin Immunol; 1992 Feb; 4(1):74-8. PubMed ID: 1596371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigens and their role in autoimmune disorders.
    Schiffenbauer J
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):17-24. PubMed ID: 11729824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Superantigens and their behavior in the immune response].
    López H; Sandoval GF; Vera JG; Solano MO
    Rev Alerg Mex; 1996; 43(1):13-7. PubMed ID: 8901035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superantigens and their role in disease.
    Kotzin BL
    Hosp Pract (Off Ed); 1994 Nov; 29(11):59-63, 68-70. PubMed ID: 7962239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Superantigens: concept and applications in the pathogenesis and treatment of infectious and autoimmune diseases].
    Quirós E; Maroto MC
    An Med Interna; 1996 Jul; 13(7):347-52. PubMed ID: 8962982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMTV superantigens coerce an unconventional topology between the TCR and MHC class II.
    Fortin JS; Genève L; Gauthier C; Shoukry NH; Azar GA; Younes S; Yassine-Diab B; Sékaly RP; Fremont DH; Thibodeau J
    J Immunol; 2014 Feb; 192(4):1896-906. PubMed ID: 24453254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigens - powerful modifiers of the immune system.
    Fraser J; Arcus V; Kong P; Baker E; Proft T
    Mol Med Today; 2000 Mar; 6(3):125-32. PubMed ID: 10689316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.